Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tasipimidine for insomnia
ISRCTN35042256Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Jul 2023
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial in Insomnia comparing Tasipimidine with Placebo (2 arms). Primary endpoint: Effect on sleep by polysomnography. Started Jul 2023; status: completed.
02
Drugs
tasipimidine
03
Conditions
Insomnia
Beyond the preview
Go deeper on ISRCTN35042256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN35042256.